ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995

October 1, 1993

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992

MSK Starts Ovarian Cancer Program

November 21, 1986

House Democrats Take More Swings At Tobacco Industry

February 17, 1989

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980